High-throughput kinetics in drug discovery

被引：1
|
作者：
Pinto, Maria Filipa [1 ]
Sirina, Julija [2 ]
Holliday, Nicholas D. [2 ,3 ]
Mcwhirter, Claire L. [1 ]
机构：
[1] Artios Pharma Ltd, B940,Babraham Res Campus, Cambridge CB22 3FH, England
[2] Excellerate Biosci Ltd, 21 Triangle,NG2 Business Pk, Nottingham NG2 1AE, England
[3] Univ Nottingham, Sch Life Sci, Med Sch, Nottingham NG7 2UH, England
来源：
SLAS DISCOVERY | 2024年 / 29卷 / 05期
关键词：
Mechanism of inhibition (MoI); High; -throughput; Enzyme kinetics; TARGET RESIDENCE TIME; BINDING-KINETICS; PHARMACOLOGICAL CHARACTERIZATION; CLINICAL PHARMACOKINETICS; ENZYME-KINETICS; LIGAND-BINDING; INHIBITORS; COVALENT; ASSAY; MECHANISMS;
D O I：
10.1016/j.slasd.2024.100170
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
The importance of a drug's kinetic profile and interplay of structure-kinetic activity with PK/PD has long been appreciated in drug discovery. However, technical challenges have often limited detailed kinetic characterization of compounds to the latter stages of projects. This review highlights the advances that have been made in recent years in techniques, instrumentation, and data analysis to increase the throughput of detailed kinetic and mechanistic characterization, enabling its application earlier in the drug discovery process.
引用
收藏
页数：14
相关论文
共 50 条
  • [21] High-throughput screening approaches to TB drug discovery
    Stanley, Sarah A.
    Grant, Sarah S.
    Barczak, Amy K.
    Hung, Deborah T.
    TUBERCULOSIS, 2013, 93 (01) : 110 - 110
  • [22] High-throughput crystallography for lead discovery in drug design
    Blundell, TL
    Jhoti, H
    Abell, C
    NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (01) : 45 - 54
  • [23] High-throughput crystallography for lead discovery in drug design
    Tom L. Blundell
    Harren Jhoti
    Chris Abell
    Nature Reviews Drug Discovery, 2002, 1 : 45 - 54
  • [24] High-throughput crystallization and structure determination in drug discovery
    Stewart, L
    Clark, R
    Behnke, C
    DRUG DISCOVERY TODAY, 2002, 7 (03) : 187 - 196
  • [25] High-throughput virtual screening for drug discovery in parallel
    Toledo-Sherman, LM
    Chen, DQ
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2002, 5 (03) : 414 - 421
  • [26] High-Throughput Purification Platform in Support of Drug Discovery
    Liu, Min
    Chen, Kuanchang
    Christian, Denny
    Fatima, Tazeen
    Pissamitski, Natalya
    Streckfuss, Eric
    Zhang, Chaowei
    Xia, Lei
    Borges, Scott
    Shi, Zhicai
    Vachal, Petr
    Tata, James
    Athanasopoulos, John
    ACS COMBINATORIAL SCIENCE, 2012, 14 (01) : 51 - 59
  • [27] C. elegans in high-throughput drug discovery
    O'Reilly, Linda P.
    Luke, Cliff J.
    Perlmutter, David H.
    Silverman, Gary A.
    Pak, Stephen C.
    ADVANCED DRUG DELIVERY REVIEWS, 2014, 69 : 247 - 253
  • [28] High-throughput kinase profiling as a platform for drug discovery
    Goldstein, David M.
    Gray, Nathanael S.
    Zarrinkar, Patrick P.
    NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (05) : 391 - 397
  • [29] Advances in high-throughput mass spectrometry in drug discovery
    Duenas, Maria Emilia
    Peltier-Heap, Rachel E.
    Leveridge, Melanie
    Annan, Roland S.
    Buttner, Frank H.
    Trost, Matthias
    EMBO MOLECULAR MEDICINE, 2023, 15 (01)
  • [30] Hypothesis Testing in High-Throughput Screening for Drug Discovery
    Prummer, Michael
    JOURNAL OF BIOMOLECULAR SCREENING, 2012, 17 (04) : 519 - 529
12345